173 related articles for article (PubMed ID: 16138264)
61. Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight.
Giapros V; Evagelidou E; Challa A; Kiortsis D; Drougia A; Andronikou S
Clin Endocrinol (Oxf); 2007 Mar; 66(3):353-9. PubMed ID: 17302868
[TBL] [Abstract][Full Text] [Related]
62. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Onat A; Hergenç G; Can G; Küçükdurmaz Z
Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
[TBL] [Abstract][Full Text] [Related]
63. Correlation of plasma leptin and adiponectin with insulin sensitivity and beta-cell function in children - the Taipei Children Heart Study.
Hung YJ; Chu NF; Wang SC; Hsieh CH; He CT; Lee CH; Fan SC
Int J Clin Pract; 2006 Dec; 60(12):1582-7. PubMed ID: 17109666
[TBL] [Abstract][Full Text] [Related]
64. [Some peculiarities of the activity of postheparin lipoprotein lipase and parameters of lipid metabolism at ischaemic heart disease].
Kavtaradze GV; Svanidze NO; Shaburishvili TSh; Tananashvili DE; Naskidashvili AI
Georgian Med News; 2006 Apr; (133):47-50. PubMed ID: 16705226
[TBL] [Abstract][Full Text] [Related]
65. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
Saiki A; Ohira M; Endo K; Koide N; Oyama T; Murano T; Miyashita Y; Shirai K
Diabetes Res Clin Pract; 2006 Dec; 74(3):242-8. PubMed ID: 16713009
[TBL] [Abstract][Full Text] [Related]
66. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance.
Straczkowski M; Kowalska I; Nikolajuk A; Otziomek E; Adamska A; Karolczuk-Zarachowicz M; Gorska M
Int J Obes (Lond); 2007 Feb; 31(2):221-5. PubMed ID: 16770329
[TBL] [Abstract][Full Text] [Related]
67. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
68. The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin.
Jang Y; Lee JH; Kim OY; Koh SJ; Chae JS; Woo JH; Cho H; Lee JE; Ordovas JM
Metabolism; 2006 Jan; 55(1):59-66. PubMed ID: 16324920
[TBL] [Abstract][Full Text] [Related]
69. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
[TBL] [Abstract][Full Text] [Related]
70. Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.
Chan DC; Watts GF; Ng TW; Hua J; Song S; Barrett PH
Diabetes Obes Metab; 2006 Nov; 8(6):698-702. PubMed ID: 17026495
[TBL] [Abstract][Full Text] [Related]
71. [Discrepancies in the measurement of serum pancreatic lipase activities by non-enzymatic and enzymatic assays, and relationships to pseudohyperlipasemia].
Konno M
Rinsho Byori; 2002 Oct; 50(10):976-81. PubMed ID: 12451678
[TBL] [Abstract][Full Text] [Related]
72. Elevated Lipoprotein Lipase Activity Does Not Account for the Association Between Adiponectin and HDL in Type 1 Diabetes.
Calderon RM; Diaz S; Szeto A; Llinas JA; Hughes TA; Mendez AJ; Goldberg RB
J Clin Endocrinol Metab; 2015 Jul; 100(7):2581-8. PubMed ID: 25942477
[TBL] [Abstract][Full Text] [Related]
73. Serum lipids and postheparin plasma lipase activity in Japanese children with ketosis-prone diabetes mellitus.
Asayama K; Amemiya S; Kato K
Tohoku J Exp Med; 1983 Dec; 141 Suppl():627-30. PubMed ID: 6440312
[TBL] [Abstract][Full Text] [Related]
74. Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women.
Urabe M; Yamamoto T; Kashiwagi T; Okubo T; Tsuchiya H; Iwasa K; Kikuchi N; Yokota K; Hosokawa K; Honjo H
Endocr J; 1996 Dec; 43(6):737-42. PubMed ID: 9075616
[TBL] [Abstract][Full Text] [Related]
75. Relationship between two AMI risk factors: low serum lipoprotein lipase mass and hypoadiponectinemia.
Hitsumoto T; Takahashi M; Iizuka T; Shirai K
J Atheroscler Thromb; 2011; 18(2):148-56. PubMed ID: 21081833
[TBL] [Abstract][Full Text] [Related]
76. Comparison of the triacylglycerol hydrolase activity of human post-heparin plasma lipoprotein lipase and hepatic triacylglycerol lipase. A monolayer study.
Jackson RL; Ponce E; McLean LR; Demel RA
Biochemistry; 1986 Mar; 25(5):1166-70. PubMed ID: 3964663
[TBL] [Abstract][Full Text] [Related]
77. Effect of platelet-activating factor on lipoprotein lipase and blood lipids.
Mimura K; Yukawa S; Mori Y; Okada K; Mune M; Nishikawa O; Hibino A; Sonobe M; Goto T; Nomoto H
Lipids; 1991 Dec; 26(12):1102-7. PubMed ID: 1819694
[TBL] [Abstract][Full Text] [Related]
78. Development and evaluation of a direct sandwich-enzyme-linked immunosorbent assay for the quantification of human hepatic triglyceride lipase mass in human plasma.
Nishimura M; Ohkaru Y; Ishii H; Sunahara N; Takagi A; Ikeda Y
J Immunol Methods; 2000 Feb; 235(1-2):41-51. PubMed ID: 10675756
[TBL] [Abstract][Full Text] [Related]
79. [Studies on the antigenic stability of hepatic triglyceride lipase in human postheparin plasma during long-term storage].
Nishimura M; Iwanaga T; Ohkaru Y; Takagi A; Ikeda Y
Yakugaku Zasshi; 2003 Jul; 123(7):587-91. PubMed ID: 12875241
[TBL] [Abstract][Full Text] [Related]
80. Sex- and age-related variations in the in vitro heparin-releasable lipoprotein lipase from mononuclear leukocytes in blood.
Maehira F; Miyagi I; Eguchi Y
Biochim Biophys Acta; 1990 Feb; 1042(3):344-51. PubMed ID: 2106346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
